Companies: 10,795·Total market cap: $144.5T
Living Cell Technologies Limited

Living Cell Technologies Limited

LVCLYOTCHealthcare
$0.03
+$0.01(+24.39%)
Market Cap$11392472
P/E Ratio
52W High$0.08
52W Low$0.02
Overview

Living Cell Technologies Limited (LVCLY) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LVCLY · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.04lvcly eps ttm · lvcly earnings per shareEarnings history
PE Ratio (TTM)lvcly pe ratio ttm · lvcly price to earningsPE Ratio deep dive
Revenue (TTM)45421.00lvcly revenue ttm · lvcly annual revenueFull revenue history
Dividend YieldNo Dividenddoes lvcly pay dividends · lvcly dividend yieldDividend history
Shares Outstanding166.3Mlvcly shares outstanding · lvcly floatShares outstanding history
Next EarningsTBAlvcly earnings date · lvcly next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$0.00▼ 100.00% YoY
202220232024
living cell technologies limited revenue · lvcly revenue 2024
FY 2024Net Income-$2.1M▲ +0.57% YoY
202220232024
living cell technologies limited net income · lvcly profit 2024
FY 2024EPS$-0.01▲ +18.75% YoY
202220232024
lvcly eps · living cell technologies limited earnings per share 2024
TTM:Revenue: $45421.00Net Income: -$4.8MEPS: $-0.04View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+22.40%
YTD-38.80%
1Y-54.33%
5Y-69.82%

About Living Cell Technologies Limited

CEODavid Richard Hainsworth
IPO DateJan 30, 2008
Employees48
CountryAU

Living Cell Technologies Limited (LCT) is a biotechnology company dedicated to the innovation, development, and market introduction of regenerative medical therapies. These treatments leverage natural…

what is living cell technologies limited · lvcly stock overview · living cell technologies limited company profile · who is living cell technologies limited ceo · lvcly OTC · living cell technologies limited headquarters · living cell technologies limited business segments

About Stock Overview & Key Data

Living Cell Technologies Limited (LVCLY) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 30, 2008. As of the latest trading session, LVCLY stock price is $0.03, with a market capitalization of $11.4M. The stock has returned -54.33% over the past 12 months and -38.80% year-to-date.

In fiscal year 2024, Living Cell Technologies Limited reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Living Cell Technologies Limited (LVCLY) stock price is $0.03. The stock is traded on OTC under the ticker symbol LVCLY. The 52-week range is $0.02 – $0.08.

LVCLY stock priceLVCLY quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice